Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000411357

Medchemexpress LLC Quipazine maleate | 5786-68-5 | >98% | 50 MG
SDP

Catalog No. 5000411357
Encompass_Preferred

Quipazine maleate is a 5-HT agonist that causes behavioral changes such as hyperactivity. It also shows a weak reversible MAO inhibitory activity. This piperazine-based nonselective serotonin receptor agonist targets several 5-HT receptor subtypes, including 5-HT₂A (pKi ≈ 6.9), 5-HT₂C (≈ 7.27), and 5-HT₂B, as well as showing marked agonist activity at 5-HT₃ (EC₅₀ ≈ 1.0 nM). It has been explored for anti-parkinsonian potential in preclinical settings and is a valuable pharmacological tool for studying serotonin receptor functions.

  • 5-HT agonist
  • Causes behavioral changes such as hyperactivity
  • Weak reversible MAO inhibitory activity
  • Nonselective serotonin receptor agonist
  • Targets 5-HT₂A, 5-HT₂C, 5-HT₂B, and 5-HT₃ receptors
  • Explored for anti-parkinsonian potential
  • Valuable pharmacological tool for studying serotonin receptor functions

Catalog No. 50-004-11357 Supplier Medchemexpress LLC Supplier No. HYB149550MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Quipazine maleate is a 5-HT agonist that causes behavioral changes such as hyperactivity. It also shows a weak reversible MAO inhibitory activity. This piperazine-based nonselective serotonin receptor agonist targets several 5-HT receptor subtypes, including 5-HT₂A (pKi ≈ 6.9), 5-HT₂C (≈ 7.27), and 5-HT₂B, as well as showing marked agonist activity at 5-HT₃ (EC₅₀ ≈ 1.0 nM). It has been explored for anti-parkinsonian potential in preclinical settings and is a valuable pharmacological tool for studying serotonin receptor functions.

  • 5-HT agonist
  • Causes behavioral changes such as hyperactivity
  • Weak reversible MAO inhibitory activity
  • Nonselective serotonin receptor agonist
  • Targets 5-HT₂A, 5-HT₂C, 5-HT₂B, and 5-HT₃ receptors
  • Explored for anti-parkinsonian potential
  • Valuable pharmacological tool for studying serotonin receptor functions

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.